05272017Headline:

Las Vegas, Nevada

HomeNevadaLas Vegas

Chrissie Cole

Several Child/Infant Medicine Products Recalled

McNeil Consumer Healthcare, a division of Johnson & Johnson, in consultation with the FDA announced a voluntary recall of 43 over-the-counter medicines made for infants and children –…

Peter Wetherall

Sandoz Inc.'s Drugs Miss The Mark

Sandoz Inc., recently received a Warning Letter, 08-ATL-13, from the FDA, advising Sandoz that an inspection of Sandoz’s manufacturing facility located at 4700 Sandoz Drive, Wilson, North Carolina…

Peter Wetherall

Congress Demands Immediate Access to Clinical Data

An FDA MedWatch Alert released Thursday, August 21, informed healthcare professionals that the FDA is investigating a report from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial of a…

Peter Wetherall

New England Journal of Medicine Urges the U.S. Supreme Court to be Skeptical

Last week, physicians came to the aid of Plaintiff’s lawyers, citizens of Clark County and the American consumer of prescription medication.    The editors of the New England Journal of Medicine…

Peter Wetherall

In Bed Together: The Potential Merger of Teva and Barr

Las Vegas consumers of generic prescription medication andAmerican consumers have much to be worried about these days.   We have discussed theinefficiencies of the FDA (given its current structure…

Peter Wetherall

Akathasia: The Worst Condition of All

Nearly all published literature on neurolepticdrugs documents that akathasia is the most common type of extrapyramidalsymptom resulting from the use of metoclopramide.   What is akathasia?   It is…

Peter Wetherall

Inadequate Warnings: What is all the Fuss About?

The “Warnings” section of themetoclopramide label contains a discussion of the possible side effects ofextrapyramidal symptoms.  It reads: WARNINGS: Extrapyramidalsymptoms, manifested primarily as…

Peter Wetherall

Medical Literature and Advances in Science: Big Pharma Can’t Read

    There are three ways that drugcompanies can ensure patient safety. First, of all, they can look at the adverse event reports which they arereceiving or that they get from the Food and Drug…

Peter Wetherall

Big Pharma:Too Lazy to Ensure Patient Safety?

Allmanufacturers and distributors of prescription pharmaceutical products in theUnited States who hold an approved New Drug Application (hereinafter “NDA”) oran Abbreviated New Drug Application…

Peter Wetherall

Profits Over Patient Safety: Metoclopramide and Big Pharma

As readers know, Reglan (the name brand) is also dispensedas Metoclopramide.  Reglan wasWyeth and Schwarz Pharma’s product.  But these two giant pharmaceutical companies aren’t the only…